Iqbal Phool, Laswi Bushra K, Kazman Rashid, Fatima Haajra, Ait Hssain Ali
Internal Medicine, Hamad Medical Corporation, Doha, QAT.
Internal Medicine, Hamad General Hospital, Doha, QAT.
Cureus. 2019 Dec 30;11(12):e6515. doi: 10.7759/cureus.6515.
Hyponatremia is one of the most common electrolyte abnormalities and is associated with many conditions. It has been reported in patients receiving diuretics as a physiological consequence of the therapy. We report an unusual case of severe hyponatremia of 100 mmol/L (Normal range (NR): 136-145 mmol/L) in a 54-year-old middle-aged gentleman within two weeks of commencement of Indapamide, a thiazide-like diuretic. After immediate treatment with intravenous 3% hypertonic saline infusion, discontinuation of indapamide, and ruling out other possible causes of hyponatremia, his serum sodium level improved. He was discharged without having any complicated hospital course and was also followed up for a further five months. The aim of our case report is to highlight an important and life-threatening complication associated with the most commonly prescribed drug and to manage it through cautious correction and monitoring of sodium levels.
低钠血症是最常见的电解质异常之一,与多种疾病相关。据报道,接受利尿剂治疗的患者会出现低钠血症,这是该治疗的生理后果。我们报告了一例不寻常的严重低钠血症病例,一名54岁的中年男性在开始使用噻嗪类利尿剂吲达帕胺两周内,血钠水平降至100 mmol/L(正常范围(NR):136 - 145 mmol/L)。经静脉输注3%高渗盐水立即治疗、停用吲达帕胺并排除其他可能导致低钠血症的原因后,他的血清钠水平有所改善。他出院时没有出现任何复杂的住院病程,并且还接受了进一步五个月的随访。我们病例报告的目的是强调与最常用药物相关的一种重要且危及生命的并发症,并通过谨慎纠正和监测血钠水平来进行处理。